Århus based biotech company attracts investment  

Borean Pharma has received a DKK 35 million cash injection from a consortium led by Bank Invest

Erhvervsbladet reports today that Borean Pharma A/S, the first Århus-based biotechnology company to attract venture capital, is growing strongly. The company, which uses a patented technology to develop pharmaceutical proteins, recently received a DKK 35 million (USD 4.7 million) cash injection from a consortium led by Bank Invest. According to Borean Pharma, further substantial investment is anticipated from the same source during the latter part of this year. Aalborg-based Novi A/S and Århus-based Incuba have also invested in Borean Pharma.


The cash injections have enabled Borean Pharma to increase its workforce from 5 to 21, and the company expects to employ a total of 35 people next year.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×